채용
Sarepta
Sarepta
Genetic medicine company
Gene Therapy
Drug Development
Clinical Research
Molecular Biology
Biostatistics
채용 중인 포지션
0개 포지션
현재 채용 중인 포지션이 없습니다
제품 및 서비스
EL
ELEVIDYS
Gene Therapy
ELEVIDYS
Gene Therapy
EXONDYS 51
Antisense Oligonucleotide
EX
EXONDYS 51
RNA-targeted Therapy
VYONDYS 53
Antisense Oligonucleotide
VY
VYONDYS 53
RNA-targeted Therapy
AMONDYS 45
Antisense Oligonucleotide
AM
AMONDYS 45
RNA-targeted Therapy
VILTEPSO
Antisense Oligonucleotide
SR
SRP-9001
Gene Therapy
CA
CASIMERSEN
RNA-targeted Therapy
SRP-9001
Gene Therapy
Limb-girdle muscular dystrophy programs
Gene Therapy
LI
Limb-girdle Muscular Dystrophy Programs
Gene Therapy
RNA-targeted therapeutics platform
Platform Technology
CH
Charcot-Marie-Tooth Disease Programs
Neuromuscular Therapy
유사 기업
Quest Diagnostics
Public
Clinical laboratory company
Secaucus, New Jersey, United States
10,001+
Valuation $10.8B
Bio-Rad
Public
Global leader in life science research and clinical diagnostics
Hercules, California, United States
5,001-10,000
Valuation $3.2B
HCA Healthcare
Public
Leading company in the healthcare industry
Nashville, Tennessee, United States
10,001+
Valuation $75B
96 open jobs
Freenome
Series C
AI genomics company for cancer detection
South San Francisco, CA
201-500
Valuation $2.3B
33 open jobs
Caribou Biosciences
Series C
CRISPR genome editing company
Berkeley, CA
201-500
4 open jobs
Editas Medicine
Public
Genome editing company
Cambridge, Massachusetts, United States
201-500
Valuation $1.2B
뉴스 & 버즈
All
X
News
HN
YouTube
H.C. Wainwright reiterates Sarepta stock Sell rating at $5 target - Investing.com
Investing.com
News
·
4일 전
Will Roche’s New Global Elevidys Phase 3 Trial Shift Sarepta Therapeutics' (SRPT) Gene Therapy Narrative? - simplywall.st
simplywall.st
News
·
4일 전
Sarepta/ Roche Duchenne therapy to face new late-stage trial targeting EU nod - Seeking Alpha
Seeking Alpha
News
·
5일 전
Roche to start new Elevidys study following setback in Europe - BioPharma Dive
BioPharma Dive
News
·
5일 전
Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy - Fierce Pharma
Fierce Pharma
News
·
5일 전
더 보기 (15개 남음)
총 조회수
0
총 지원 클릭 수
0
모의 지원자 수
0
스크랩
0
리뷰
3.8
48개 리뷰
워라밸
3.5
보상
3.9
문화
4.0
커리어
4.0
경영진
3.6
76%
친구에게 추천
장점
Good work-life balance and flexible environment
Supportive team and management
Competitive compensation and benefits
단점
Some organizational bureaucracy
Room for improvement in processes
Work-life balance varies by team
연봉 정보
47개 데이터
Director
Mid/L4
Senior/L5
Director
3개 리포트
$243,750
총 연봉
기본급
$187,500
주식
-
$240,500
$247,000
면접 경험
5개 면접
난이도
2.2
/ 5
소요 기간
2-5w
합격률
40%
경험
긍정 60%
보통 20%
부정 20%
면접 과정
1
Application Review
2
HR/Recruiter Screen
3
Technical/Phone Screen
4
Hiring Manager Interview
5
Panel/Onsite Interviews
6
Offer
연락처 및 위치